Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rituo is a regenerative skin product developed by L&C Bio, utilizing human-derived acellular dermal matrix (ADM) technology. It is specifically formulated as a "skin booster" or tissue-regenerative material composed of concentrated human collagen (C-ADM). The product is designed to restore the skin's extracellular matrix (ECM) by providing a natural scaffold that promotes cellular proliferation, migration, and tissue repair. It is primarily used in dermatology for skin rejuvenation, improving skin elasticity, and accelerating wound healing. Unlike traditional ADM sheets, Rituo is processed into a form suitable for targeted application or injection to enhance the skin's internal environment. L&C Bio has significantly expanded its production capacity for Rituo to support its entry into international markets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Rituo.